In Vitro and In Vivo Evaluation of Diclofenac Sodium Gel Prepared with Cellulose Ether and Carbopol 934P

被引:13
作者
Baviskar, Dheeraj T. [1 ]
Biranwar, Yogeshkumar A. [1 ]
Bare, Kapil R. [1 ]
Parik, Venkatesh B. [1 ]
Sapate, Mangesh K. [1 ]
Jain, Dinesh K. [2 ]
机构
[1] Inst Pharmaceut Educ, Dept Pharmaceut, Tal Shirpur 425428, Maharashtra, India
[2] IPS Acad, Coll Pharm, Dept Pharmaceut, Indore 452012, MP, India
关键词
Diclofenac sodium; Anti-inflammatory; Hydroxypropyl methylcellulose; Carbopol; Drug release; Glycerin; HYDROXYPROPYL METHYLCELLULOSE; RELEASE; IBUPROFEN;
D O I
10.4314/tjpr.v12i4.7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose: To develop diclofenac sodium gel using high molecular weight hydroxypropyl methylcellulose (HPMC) and Carbopol 934P for topical and systemic delivery. Methods: Diclofenac sodium gel was prepared with HPMC K100M and Carbopol 934P as gelling agents. The formulations were examined for pH, spreadability, consistency, viscosity, homogeneity, drug content and stability. In vitro drug release was evaluated using Franz diffusion cell. Carrageenan-induced rat paw oedema model was used for the evaluation of the anti-inflammatory activity of the gels. A commercial diclofenac sodium gel product was used as the reference drug. Results: Formulations containing glycerin as permeation enhancer gave drug release patterns comparable to that of the reference product. The drug content of F-2, F-5 and F-9 was 99.81, 99.75 and 99.96 %, respectively. Accelerated stability results showed no significant variation in the appearance and drug release after storage for 3 months. Conclusion: Diclofenac sodium gel containing HPMC K100M and Carbopol 934P exhibited pronounced anti-inflammatory activity and could be further developed for topical and systemic delivery..
引用
收藏
页码:489 / 494
页数:6
相关论文
共 17 条
[1]  
[Anonymous], 2007, INDIAN PHARMACOPOEIA, V1, p[289, 1020, 148]
[2]  
Awasthi S., 2009, Ethnobotanical leaflets, V13, P568
[3]   PIROXICAM RELEASE FROM DERMATOLOGICAL BASES - INVITRO STUDIES USING CELLULOSE MEMBRANE AND HAIRLESS MOUSE SKIN [J].
BABAR, A ;
SOLANKI, UD ;
CUTIE, AJ ;
PLAKOGIANNIS, F .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1990, 16 (03) :523-540
[4]   The role of menthol in skin penetration from topical formulations of ibuprofen 5% in vivo [J].
Brain, KR ;
Green, DM ;
Dykes, PJ ;
Marks, R ;
Bola, TS .
SKIN PHARMACOLOGY AND PHYSIOLOGY, 2006, 19 (01) :17-21
[5]   An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs [J].
Brown, MB ;
Hanpanitcharoen, M ;
Martin, GP .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 225 (1-2) :113-121
[6]   UPDATE ON IBUPROFEN - REVIEW ARTICLE [J].
BUSSON, M .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1986, 14 (02) :53-62
[7]   Microemulsion-based hydrogel formulation of ibuprofen for topical delivery [J].
Chen, Huabing ;
Chang, Xueling ;
Du, Danrong ;
Li, Jin ;
Xu, Huibi ;
Yang, Xiangliang .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 315 (1-2) :52-58
[8]  
Daniels Rolf, 2007, J Dtsch Dermatol Ges, V5, P367, DOI 10.1111/j.1610-0387.2007.06321.x
[9]  
Enayatifard R, 2009, TROP J PHARM RES, V8, P425
[10]  
Golinkin SH, 1979, US Patent, Patent No. [US 4137182, 4137182]